Lopez-Quintero, C., et al., Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend, 2011. 115(1-2): p. 120-30.
Hall, W. and L. Degenhardt, Adverse health effects of non-medical cannabis use. Lancet, 2009. 374(9698): p. 1383-91.
Budney, A.J., J.D. Sargent, and D.C. Lee, Vaping cannabis (marijuana): parallel concerns to e-cigs? Addiction, 2015. 110(11): p. 1699-704.
American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 5th ed., American Psychiatric Association, Editor. 2013, Arlington, VA.
Meier, M.H., et al., Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A, 2012. 109(40): p. E2657-64.
Filbey, F.M., et al., Long-term effects of marijuana use on the brain. Proc Natl Acad Sci U S A, 2014. 111(47): p. 16913-8.
Goldschmidt, L., N.L. Day, and G.A. Richardson, Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol, 2000. 22(3): p. 325-36.
Fried, P.A., B. Watkinson, and R. Gray, Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol, 1998. 20(3): p. 293-306.
Leech, S.L., et al., Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol Teratol, 1999. 21(2): p. 109-18.
Goldschmidt, L., et al., Prenatal marijuana exposure and intelligence test performance at age 6. J Am Acad Child Adolesc Psychiatry, 2008. 47(3): p. 254-63.
El Marroun, H., et al., Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend, 2011. 118(2-3): p. 470-4.
US Department of Health and Human Services, The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General, Centers for Disease Control and Prevention, Editor. 2014: Atlanta, GA.
Sidney, S., et al., Marijuana use and cancer incidence (California, United States). Cancer Causes Control, 1997. 8(5): p. 722-8.
Gurney, J., et al., Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC Cancer, 2015. 15: p. 897.
Sidney, S., Cardiovascular consequences of marijuana use. J Clin Pharmacol, 2002. 42(11 Suppl): p. 64S-70S.
Aronow, W.S. and J. Cassidy, Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med, 1974. 291(2): p. 65-7.
Mittleman, M.A., et al., Triggering myocardial infarction by marijuana. Circulation, 2001. 103(23): p. 2805-9.
Wolff, V., et al., Cannabis-related stroke: myth or reality? Stroke, 2013. 44(2): p. 558-63.
Wolff, V., et al., Characteristics and Prognosis of Ischemic Stroke in Young Cannabis Users Compared With Non-Cannabis Users. J Am Coll Cardiol, 2015. 66(18): p. 2052-3.
Franz, C.A. and W.H. Frishman, Marijuana Use and Cardiovascular Disease. Cardiol Rev, 2016. 24(4): p. 158-62.
Rumalla, K., A.Y. Reddy, and M.K. Mittal, Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States. J Neurol Sci, 2016. 364: p. 191-6.
Rumalla, K., A.Y. Reddy, and M.K. Mittal, Association of Recreational Marijuana Use with Aneurysmal Subarachnoid Hemorrhage. J Stroke Cerebrovasc Dis, 2016. 25(2): p. 452-60.
Tashkin, D.P., Effects of marijuana smoking on the lung. Ann Am Thorac Soc, 2013. 10(3): p. 239-47.
Moir, D., et al., A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol, 2008. 21(2): p. 494-502.
Aldington, S., et al., Effects of cannabis on pulmonary structure, function and symptoms. Thorax, 2007. 62(12): p. 1058-63.
Bloom, J.W., et al., Respiratory effects of non-tobacco cigarettes. Br Med J (Clin Res Ed), 1987. 295(6612): p. 1516-8.
Moore, C., et al., Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Sci Int, 2011. 212(1-3): p. 227-30.
Tan, W.C., et al., Marijuana and chronic obstructive lung disease: a population-based study. CMAJ, 2009. 180(8): p. 814-20.
Tashkin, D.P., et al., Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis, 1987. 135(1): p. 209-16.
Taylor, D.R., et al., The respiratory effects of cannabis dependence in young adults. Addiction, 2000. 95(11): p. 1669-77.
Hancox, R.J., et al., Effects of quitting cannabis on respiratory symptoms. Eur Respir J, 2015. 46(1): p. 80-7.
Tashkin, D.P., M.S. Simmons, and C.H. Tseng, Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis. COPD, 2012. 9(4): p. 367-74.
Cone, E.J., et al., Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results. J Anal Toxicol, 2015. 39(1): p. 1-12.
Zarfin, Y., et al., Infant with altered consciousness after cannabis passive inhalation. Child Abuse Negl, 2012. 36(2): p. 81-3.
National Institute on Drug Abuse, Marijuana, in Research Report Series. 2015, National Institutes of Health; U.S. Department of Health and Human Services.
Large, M., et al., Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry, 2011. 68(6): p. 555-61.
Arseneault, L., et al., Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ, 2002. 325(7374): p. 1212-3.
Di Forti, M., et al., Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull, 2014. 40(6): p. 1509-17.
Di Forti, M., et al., High-potency cannabis and the risk of psychosis. Br J Psychiatry, 2009. 195(6): p. 488-91.
Di Forti, M., et al., Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry, 2015. 2(3): p. 233-8.
National Institute on Drug Abuse, Preventing Drug Use among Children and Adolescents (In Brief). National Institutes of Health; U.S. Department of Health and Human Services.
Natividad L, M.P., Parsons LH, Cannabinoid-alcohol interactions, in Cannabinoid Modulation of Emotion, Memory, and Motivation, P. Campolongo, Editor. 2013, Springer: New York, NY. p. 363-391.
Hartman, R.L., et al., Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend, 2015. 154: p. 25-37.
Dubois, S., et al., The combined effects of alcohol and cannabis on driving: Impact on crash risk. Forensic Sci Int, 2015. 248: p. 94-100.
Peters, E.N., A.J. Budney, and K.M. Carroll, Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction, 2012. 107(8): p. 1404-17.
Barsky, S.H., et al., Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst, 1998. 90(16): p. 1198-205.
Fligiel, S.E., et al., Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest, 1997. 112(2): p. 319-26.
Agrawal, A., A.J. Budney, and M.T. Lynskey, The co-occurring use and misuse of cannabis and tobacco: a review. Addiction, 2012. 107(7): p. 1221-33.
Secades-Villa, R., et al., Probability and predictors of the cannabis gateway effect: a national study. Int J Drug Policy, 2015. 26(2): p. 135-42.
Panlilio, L.V., et al., Prior exposure to THC increases the addictive effects of nicotine in rats. Neuropsychopharmacology, 2013. 38(7): p. 1198-208.
Levine, A., et al., Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Sci Transl Med, 2011. 3(107): p. 107-9.
Colorado Department of Public Health and Environment. Monitoring Health Concerns Related to Marijuana in Colorado: 2014. 2015 [cited 2016 July 11, 2016].
Mark, K., A. Desai, and M. Terplan, Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes. Arch Womens Ment Health, 2016. 19(1): p. 105-11.
Warner, T.D., D. Roussos-Ross, and M. Behnke, It’s not your mother’s marijuana: effects on maternal-fetal health and the developing child. Clin Perinatol, 2014. 41(4): p. 877-94.
Bloomfield, M.A., et al., The effects of Delta9-tetrahydrocannabinol on the dopamine system. Nature, 2016. 539(7629): p. 369-377.
Macleod, J., et al., Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet, 2004. 363(9421): p. 1579-88.
Fergusson, D.M. and J.M. Boden, Cannabis use and later life outcomes. Addiction, 2008. 103(6): p. 969-76; discussion 977-8.
Brook, J.S., et al., Adult work commitment, financial stability, and social environment as related to trajectories of marijuana use beginning in adolescence. Subst Abus, 2013. 34(3): p. 298-305.
Tang, Z. and R.G. Orwin, Marijuana initiation among American youth and its risks as dynamic processes: prospective findings from a national longitudinal study. Subst Use Misuse, 2009. 44(2): p. 195-211.
Roditis, M.L. and B. Halpern-Felsher, Adolescents’ Perceptions of Risks and Benefits of Conventional Cigarettes, E-cigarettes, and Marijuana: A Qualitative Analysis. J Adolesc Health, 2015. 57(2): p. 179-85.
Perez-Reyes, M., M.E. Wall, Presence of Î”9-tetrahydrocannabinol in human milk. N Engl J Med, 1982. 307(13): p. 819-20.